Rethinking Clinical Trials

NOVEMBER 1, 2022

Department of Population Health Sciences. Vanderbilt University Medical Center. Duke Clinical Research Institute. Duke University School of Medicine. Russell Rothman, MD, MPP. Senior Vice President, Population and Public Health. Director, Vanderbilt Institute for Medicine and Public Health. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Research Vaccination Vaccine 130

pharmaphorum

DECEMBER 17, 2020

She told the BBC that her approach on TikTok is “come for the entertainment, but stay for the science.” Her videos cover a host of topics from the science behind the immune system, side effects caused by the shots and vaccine hesitancy and the clinical and regulatory path to approval. Dr Austin Chiang.

Scientist 91

Scientist Vaccination Vaccine Medicine 91

Rethinking Clinical Trials

FEBRUARY 9, 2023

This trial tested the hypothesis that the use of a platform-agnostic, EHR-embedded VTE risk model with integrated CDS would 1) increase rates of appropriate Thromboprophylaxis, and subsequently 2) reduce thromboembolism, compared to usual medical care in hospitalized, medically-ill patients.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

XTalks

AUGUST 31, 2022

The approval makes Auvelity the first and only rapid-acting oral medication for depression, and the first and only oral NMDA receptor antagonist approved for MDD. Hear more about the therapy, some of the setbacks bluebird has had to face on the road to its approval and why the treatment has a steep price tag. Bluebird’s $2.8M

Gene Therapy 52

Gene Therapy FDA Approval Life Science Gene 52

Rethinking Clinical Trials

FEBRUARY 28, 2024

Note that the release of medical records may be needed for health systems unrelated to sites. Tags #pctGR, @Collaboratory1 The post Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD) appeared first on Rethinking Clinical Trials.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

OCTOBER 26, 2023

point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. To address this crisis, the NIH is embarking on a National Initiative on Hepatitis C. The initiative would bring to the U.S.

Clinical Research 141

Clinical Research Clinical Trials Clinical Trials Research 141

Rethinking Clinical Trials

NOVEMBER 16, 2022

Associate Director, Center for Bioethics & Social Sciences in Medicine. University of Michigan Medical School. Berman Institute of Bioethics & Johns Hopkins Bloomberg School of Public Health. Kayte Spector-Bagdady, JD, MBioethics. Assistant Professor of Obstetrics & Gynecology. Key Points. pctGR, @Collaboratory1.

Clinical Trials 246

Clinical Trials Clinical Trials Trials Research 246

Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Rethinking Clinical Trials

FEBRUARY 20, 2024

             Speaker Jeffrey Carson, MD, MACP Principal Investigator and Study Chair MINT Trial Provost-New Brunswick, Rutgers Biomedical Health Sciences Distinguished Professor of Medicine Richard C. Reynolds, M.D. In general, I think as these things go, it was quite positive.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

The Pharma Data

MARCH 16, 2022

The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Early Excellence in Science Awards 2020.

Protein 52

Protein Scientist Gene Development 52

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Branding 116

Branding Marketing Pharma Companies Life Science 116

World of DTC Marketing

JUNE 23, 2021

In my career in healthcare marketing, I have done my best to understand the “science” behind certain health conditions along with how some medications can help. When I didn’t understand something, I went to the medical people on the team to gain insights. Not to mention the $56,000 annual price tag.

Drugs 218

Drugs FDA Approval Doctors Doctor 218

Rethinking Clinical Trials

SEPTEMBER 22, 2022

Department of Biomedical Sciences. Faculty of Health and Medical Sciences. Researchers can track participants through their medical records regardless of location and through the national registries. Professor in Translational Cardiology and Pragmatic Randomized Trials. University of Copenhagen. Department of Cardiology.

Trials 130

Trials Cardiology Vaccination Vaccine 130

Rethinking Clinical Trials

MAY 10, 2023

Denny, MD, MS CEO, All of Us Research Program Slides Keywords Precision Medicine, All of Us Research Program Key Points The mission of the All of Us Research Program is to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us. Those funds would come from NIH.

Medicine 130

Medicine Research Clinical Trials Clinical Trials 130

Drug Discovery World

JANUARY 9, 2023

In this early research, Khalid Shah, Professor of Neurosurgery at Harvard Medical School and Brigham and Women’s Hospital, and colleagues tested the vaccine in an advanced mouse model of brain cancer glioblastoma, with promising results. The findings are published in Science Translational Medicine. .

Scientist 52

Scientist Gene Editing Gene Engineer 52

Rethinking Clinical Trials

OCTOBER 27, 2022

Chief Science & Digital Officer. Professor, Department of Population Health Sciences. Perakslis said his definition of digital health is any time you mix medical information and the internet. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Eric Perakslis, PhD. Andrea Downing.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

MARCH 28, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds March 24, 2023: From Observational Studies to Pragmatic Clinical Trials: (Almost) A Decade of Research in PCORnet® (Erin Holve, PhD, MPH, MPP; Russell Rothman, MD, MPP; Schuyler Jones, MD; Neha Pagidipati, MD, MPH) appeared first on Rethinking Clinical Trials.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Roots Analysis

JANUARY 28, 2024

The concept of big data is often described using three key characteristics, known as the 3 V’s, as coined by Doug Laney in the early 2000s: Volume: Big data is collected from a wide range of sources, like transactions, Internet of Medical Things (IoMT), industrial equipment, videos, images, audio, and social media.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 90

Regulation Marketing Sales Branding 90

The Pharma Data

NOVEMBER 29, 2021

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries.

Vaccination 52

Vaccination Vaccine Genome Genomics 52

Drug Discovery World

MAY 22, 2023

Ryan Leahy , a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. But are these price tags a barrier to access? million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

pharmaphorum

JUNE 12, 2022

Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price. Beti-cel offers another potentially curative treatment for a much broader range of patients.

Gene Therapy 57

Gene Therapy Gene Marketing Trials 57

pharmaphorum

JANUARY 21, 2022

Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Flawed funding model. About the author.

Medicine 52

Medicine Marketing Manufacturing Production 52

The Pharma Data

DECEMBER 3, 2020

Rob Janssen, Chief Medical Officer of Dynavax, commented, “We are pleased with the strong immune responses and an outstanding safety profile of Clover’s S-Trimer vaccine adjuvanted with Dynavax’s advanced CpG 1018 adjuvant plus alum. About Trimer-Tag © Technology. About COVID-19 S-Trimer Vaccine. S-Trimer is intended to be adjuvanted.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. While E6(R3) provides a foundation for GCP expectations, guidelines alone are not adequate.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. While E6(R3) provides a foundation for GCP expectations, guidelines alone are not adequate.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

OCTOBER 29, 2021

Hopefully a new standard of care for the aggressive disease, according to partners Gilead Sciences and Merck & Co. “This helps further our ambition of displacing chemotherapy with Trodelvy to improve outcomes for people living with cancer,” said Gilead’s chief medical officer Merdad Parsey.

Trials 52

Trials Sales FDA Approval Production 52

The Pharma Data

OCTOBER 9, 2021

This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies. Roche’s Chief Medical Officer and Head of Global Product Development.

Antibody 52

Antibody In-Vitro Trials Development 52

Rethinking Clinical Trials

APRIL 13, 2023

It works to improve health care value and outcomes, advance the science of designing interventions to change behavior and evaluate and disseminate the impact of interventions. The team then worked to incorporate an implementation science lens for designing interventions for scale to the health system.

Medicine 100

Medicine Trials Cardiology Development 100

pharmaphorum

NOVEMBER 16, 2022

However, with a price tag of €1.58 However, a recently released report from the organisation could blow the price tag of Zolgensma out of the water. When even high-income regions like Europe are refusing to meet the price tag of certain gene therapies, it is likely the debate on pricing is set to continue in the long-term.

Gene Therapy 129

Gene Therapy Gene Marketing Development 129

XTalks

DECEMBER 21, 2022

The past year has been a strong one for life sciences industries, from pivotal gene therapy approvals to continued innovations in the biotech and medical device spaces. Here are some of the top life science trends and topics from 2022. The life sciences continued to be driven by advanced technologies during the past year.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

XTalks

FEBRUARY 17, 2023

Here are six key tactics life science marketers should use to drive increased registration numbers for their webinars. 6) Tagging Speakers and Partners It’s a great idea to tag your speakers and partners when promoting your webinar. Target various groups with specific messages that will resonate with them.

Life Science 97

Life Science Marketing Production 97

pharmaphorum

NOVEMBER 28, 2022

Innovation thrives in collaboration, not in isolation – and the open sourcing of Substra is a landmark moment in the use of collaborative AI in medical research,” Ibrahim Haddad, general manager of the LF AI & Data Foundation, said in a statement. Open source is undoubtedly the future of AI research.”.

Pharma Companies 70

Pharma Companies Life Science Research Development 70

XTalks

AUGUST 23, 2021

Such an event represents what should be a celebrated milestone, a culmination of decades of research, and millions, if not billions, of dollars of investment in science,” said Joshua D. Sperling, MD, a neurologist at Massachusetts General Hospital, and professor of neurology at Harvard Medical School.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Drug Discovery World

NOVEMBER 13, 2023

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.

Protein 59

Protein Antibody Engineer Scientist 59

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. ICON acquired PRA Health Sciences in 2021, the same year that Inotiv acquired Envigo.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 9, 2023

Peter O’Callaghan, PhD, Head of Expression System Sciences, Biologics and Licensing, Lonza, on: ‘Solve bispecific heavy-light chain mispairing with bYlok technology’. James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’.

Engineer 52

Engineer Antibody Protein In-Vivo 52